CTNND1 and neoplasm: Next, we intersected immunotherapy-associated differential genes with anoikis-related genes, and the genes significantly expressed in tumor cells, obtaining a special biomarker: CTNND1, which can be inferred as an immunotherapy and tumor anoikis related biomarker (Figure 2B).